Cargando…
Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma
Glaucoma is a progressive neurodegenerative disease that represents the major cause of irreversible blindness. Recent findings have shown which oxidative stress, inflammation, and glutamatergic pathway have main roles in the causes of glaucoma. Lithium is the major commonly used drug for the therapy...
Autores principales: | Vallée, Alexandre, Vallée, Jean-Noël, Lecarpentier, Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146329/ https://www.ncbi.nlm.nih.gov/pubmed/33925885 http://dx.doi.org/10.3390/biomedicines9050473 |
Ejemplares similares
-
Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma
por: Vallée, Alexandre, et al.
Publicado: (2021) -
Parkinson’s Disease: Potential Actions of Lithium by Targeting the WNT/β-Catenin Pathway, Oxidative Stress, Inflammation and Glutamatergic Pathway
por: Vallée, Alexandre, et al.
Publicado: (2021) -
Lithium: a potential therapeutic strategy in obsessive–compulsive disorder by targeting the canonical WNT/β pathway
por: Vallée, Alexandre, et al.
Publicado: (2021) -
Potential role of cannabidiol in Parkinson’s disease by targeting the WNT/β-catenin pathway, oxidative stress and inflammation
por: Vallée, Alexandre, et al.
Publicado: (2021) -
Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs
por: Vallée, Alexandre, et al.
Publicado: (2019)